Literature DB >> 5799518

Sputum liquefying agents: a comparative in vitro evaluation.

S R Hirsch, J E Zastrow, R C Kory.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5799518

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  15 in total

1.  [Clinical-pharmacological studies on bronchosecretolysis].

Authors:  T C Medici; S Chodosh
Journal:  Pneumonologie       Date:  1975-09-26

2.  Mucus strands from submucosal glands initiate mucociliary transport of large particles.

Authors:  Anthony J Fischer; Maria I Pino-Argumedo; Brieanna M Hilkin; Cullen R Shanrock; Nicholas D Gansemer; Anna L Chaly; Keyan Zarei; Patrick D Allen; Lynda S Ostedgaard; Eric A Hoffman; David A Stoltz; Michael J Welsh; Mahmoud H Abou Alaiwa
Journal:  JCI Insight       Date:  2019-01-10

3.  Mechanical homogenization increases bacterial homogeneity in sputum.

Authors:  Joshua R Stokell; Ammad Khan; Todd R Steck
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Glycoprotein analysis of middle ear effusions by rectin-conjugated sepharose affinity chromatography.

Authors:  K Sakakura; Y Hamaguchi; Y Majima; K Ukai; Y Sakakura
Journal:  Arch Otorhinolaryngol       Date:  1986

5.  Simple method for quantifying viable bacterial numbers in sputum.

Authors:  A Pye; R A Stockley; S L Hill
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

6.  Use of a mucolytic agent (Cytoclair) in the preparation of cell material for the detection of malignant cells in sputum.

Authors:  J M Grainger; O A Husain
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

7.  The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.

Authors:  S W Clarke; M T Lopez-Vidriero; D Pavia; M L Thomson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

8.  A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.

Authors:  F Ratjen; R Wönne; H G Posselt; B Stöver; D Hofmann; S W Bender
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

9.  Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Authors:  P H Weller; D Ingram; M A Preece; D J Matthew
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

10.  Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.

Authors:  S R Hirsch; P F Viernes; R C Kory
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.